GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brawn Biotech Ltd (BOM:530207) » Definitions » EV-to-Revenue

Brawn Biotech (BOM:530207) EV-to-Revenue : 0.41 (As of May. 26, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Brawn Biotech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Brawn Biotech's enterprise value is ₹67.3 Mil. Brawn Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹162.4 Mil. Therefore, Brawn Biotech's EV-to-Revenue for today is 0.41.

The historical rank and industry rank for Brawn Biotech's EV-to-Revenue or its related term are showing as below:

BOM:530207' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.04   Med: 0.21   Max: 0.82
Current: 0.41

During the past 13 years, the highest EV-to-Revenue of Brawn Biotech was 0.82. The lowest was 0.04. And the median was 0.21.

BOM:530207's EV-to-Revenue is ranked better than
93.75% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs BOM:530207: 0.41

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Brawn Biotech's stock price is ₹27.47. Brawn Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹54.38. Therefore, Brawn Biotech's PS Ratio for today is 0.51.


Brawn Biotech EV-to-Revenue Historical Data

The historical data trend for Brawn Biotech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brawn Biotech EV-to-Revenue Chart

Brawn Biotech Annual Data
Trend Mar13 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.10 0.18 0.63 0.22

Brawn Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.22 0.19 0.27 0.40

Competitive Comparison of Brawn Biotech's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Brawn Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brawn Biotech's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brawn Biotech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Brawn Biotech's EV-to-Revenue falls into.



Brawn Biotech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Brawn Biotech's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=67.295/162.439
=0.41

Brawn Biotech's current Enterprise Value is ₹67.3 Mil.
Brawn Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹162.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brawn Biotech  (BOM:530207) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Brawn Biotech's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=27.47/54.375
=0.51

Brawn Biotech's share price for today is ₹27.47.
Brawn Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹54.38.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brawn Biotech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Brawn Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Brawn Biotech (BOM:530207) Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 30, Sector 33, Near Hero Honda Factory, Gurugram, HR, IND, 122001
Brawn Biotech Ltd is a healthcare company. It is primarily engaged in the business activity of wholesale of pharmaceutical and medical goods. The company's pharmaceutical goods cover product segments like Antibacterial, Cardiovascular, Anti-diabetic, Analgesics, Gastrointestinal, Antifungals, Skin Care, Antipsychotics, Anti-asthmatic, Antacids, Antimalarial, and Nutritionals. It markets pharmaceutical products in India and internationally. The company generates a major portion of its revenue from exports.

Brawn Biotech (BOM:530207) Headlines

No Headlines